Tea

Creso to release immunity boosting CBD hemp teas in Q3

Finfeed Archived Mar 24, 2020

The $9.9 million capped Australian-listed Creso Pharma Limited (ASX: CPH) is set to release CBD hemp teas in Q3 2020